Protection against cholera toxin after oral immunization is thymus-dependent and associated with intestinal production of neutralizing IgA antitoxin
- PMID: 3576135
- DOI: 10.1111/j.1365-3083.1987.tb02208.x
Protection against cholera toxin after oral immunization is thymus-dependent and associated with intestinal production of neutralizing IgA antitoxin
Abstract
We studied whether gut mucosal IgA antitoxin production as well as the acquired protection against cholera toxin (CT) after oral immunization with CT are both thymus-dependent immune manifestations. In contrast to normal BALB/c mice, nude, athymic mice did not respond to oral immunizations with CT with either IgA antitoxin-producing cells (SFC) in the lamina propria or protection against challenge with CT in ligated intestinal loops. However, when nude mice were first reconstituted by grafting of syngeneic thymus glands, both IgA antitoxin SFC in the lamina propria and protection were stimulated by oral immunizations with CT and the response were of similar magnitude to those of normal mice after immunizations. During in vitro culture, isolated lamina propria lymphocytes from immunized but not from control mice concomitantly and proportionally produced IgA antitoxin and CT-neutralizing activity. We conclude that intestinal antitoxin formation and protection against toxin challenge after oral immunization with CT are both critically thymus-dependent and therefore likely to be under T-cell control.
Similar articles
-
Role of local IgA antitoxin-producing cells for intestinal protection against cholera toxin challenge.Int Arch Allergy Appl Immunol. 1989;88(3):273-9. doi: 10.1159/000234806. Int Arch Allergy Appl Immunol. 1989. PMID: 2785966
-
Long-term cholera antitoxin memory in the gut can be triggered to antibody formation associated with protection within hours of an oral challenge immunization.Scand J Immunol. 1987 Apr;25(4):407-12. doi: 10.1111/j.1365-3083.1987.tb02207.x. Scand J Immunol. 1987. PMID: 3576134
-
Host defense against cholera toxin is strongly CD4+ T cell dependent.Infect Immun. 1991 Oct;59(10):3630-8. doi: 10.1128/iai.59.10.3630-3638.1991. Infect Immun. 1991. PMID: 1910010 Free PMC article.
-
A sensitive method for the detection of specific antibody production in different isotypes from single lamina propria plasma cells.Scand J Immunol. 1986 Oct;24(4):393-403. doi: 10.1111/j.1365-3083.1986.tb02127.x. Scand J Immunol. 1986. PMID: 3764344
-
Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.Am J Trop Med Hyg. 1994;50(5 Suppl):42-54. Am J Trop Med Hyg. 1994. PMID: 8203723 Review.
Cited by
-
Beyond the Finish Line: The Impact and Dynamics of Biomarkers in Physical Exercise-A Narrative Review.J Clin Med. 2021 Oct 27;10(21):4978. doi: 10.3390/jcm10214978. J Clin Med. 2021. PMID: 34768497 Free PMC article. Review.
-
Relationship between Saliva and Sublingual Immunotherapy.Pathogens. 2021 Oct 21;10(11):1358. doi: 10.3390/pathogens10111358. Pathogens. 2021. PMID: 34832517 Free PMC article. Review.
-
Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy.J Clin Invest. 2004 Mar;113(6):826-35. doi: 10.1172/JCI20096. J Clin Invest. 2004. PMID: 15067315 Free PMC article.
-
Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA.Sci Immunol. 2021 Dec 10;6(66):eabj5129. doi: 10.1126/sciimmunol.abj5129. Epub 2021 Dec 10. Sci Immunol. 2021. PMID: 34890255 Free PMC article.
-
Vaccine Strategies to Elicit Mucosal Immunity.Vaccines (Basel). 2024 Feb 13;12(2):191. doi: 10.3390/vaccines12020191. Vaccines (Basel). 2024. PMID: 38400174 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous